Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 288 entries
View as:

Evaluate the Drug-drugs Interaction Between Lobeglitazone and Empagliflozin

Phase: N/A Priority: Normal
NCT ID: NCT02854748 Org: User:
Start: 08/31/16 End: 09/30/16 Due: 09/30/17

Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03887858 Org: User:
Start: 03/11/19 End: 05/07/19 Due: 05/07/20

Study to Investigate the Effect of Food on the Pharmacokinetics/Pharmacodynamics and Safety of CKD-519(CKD-519 FDI)

Phase: N/A Priority: Normal
NCT ID: NCT02484482 Org: User:
Start: 06/30/15 End: 08/31/15 Due: 08/31/16

CKD-396 Drug-drug Interaction Study(A) (CKD-396 DDI(A) P1)

Phase: N/A Priority: Normal
NCT ID: NCT02824874 Org: User:
Start: 04/30/16 End: 05/31/16 Due: 05/31/17

A Clinical Trial to Evaluate the Food Effect on Pharmacokinetic Profiles and Safety of CKD-379

Phase: N/A Priority: Normal
NCT ID: NCT06204107 Org: User:
Start: 11/21/23 End: 12/06/23 Due: 12/06/24

CKD-828 Primary Hypertension Trial(Dose-selection)

Phase: N/A Priority: Normal
NCT ID: NCT01128322 Org: User:
Start: 07/31/10 End: 03/31/11 Due: 03/31/12

The Pharmacokinetic Interaction Between CKD-501 and Sulfonylurea

Phase: N/A Priority: Normal
NCT ID: NCT01133431 Org: User:
Start: 05/31/10 End: 08/31/10 Due: 08/31/11

Pharmacokinetic Study of CKD-810 and Taxotere to Treat Patient With Advanced Solid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01019941 Org: User:
Start: 08/31/09 End: 12/31/10 Due: 12/31/11

Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05931224 Org: User:
Start: 06/28/23 End: 05/13/24 Due: 05/13/25

Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-378 and Co-administration of D745, D150, D029 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05881213 Org: User:
Start: 06/01/23 End: 07/10/23 Due: 07/10/24

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT06399055 Org: User:
Start: 09/16/22 End: 10/09/22 Due: 10/09/23

Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT03849261 Org: User:
Start: 01/14/19 End: 02/22/19 Due: 02/22/20

Comparative Evaluation of Pharmacokinetics After CKD-501 Between Renal Impaired and Normal Renal Function Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02007941 Org: User:
Start: 04/30/14 End: 04/30/15 Due: 04/30/16

CKD-841 Pharmacokinetic/Pharmacodynamic Study

Phase: N/A Priority: Normal
NCT ID: NCT03233932 Org: User:
Start: 04/30/16 End: 07/31/17 Due: 07/31/18

Study to Evaluate the Safety and Pharmacokinetics of CKD-349 in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05089279 Org: User:
Start: 11/03/21 End: 04/06/22 Due: 04/06/23

Pharmacokinetics and Safety/Tolerability of CKD-379

Phase: N/A Priority: Normal
NCT ID: NCT05719155 Org: User:
Start: 02/27/23 End: 04/10/23 Due: 04/10/24

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2)

Phase: N/A Priority: Normal
NCT ID: NCT04883658 Org: User:
Start: 06/04/21 End: 08/19/21 Due: 08/19/22

Evaluate the Drug-drugs Interaction Between Lobeglitazone 0.5mg and Empagliflozin 25mg

Phase: N/A Priority: Normal
NCT ID: NCT04869800 Org: User:
Start: 05/27/21 End: 06/15/21 Due: 06/15/22

Clinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04952506 Org: User:
Start: 07/19/21 End: 08/20/21 Due: 08/20/22

CKD-828 Telmisartan Non-Responder Trial

Phase: N/A Priority: Normal
NCT ID: NCT01426100 Org: User:
Start: 08/31/11 End: 08/31/12 Due: 08/31/13

The Effect of Food on the Pharmacokinetic Characteristics of CKD-501

Phase: N/A Priority: Normal
NCT ID: NCT01071720 Org: User:
Start: 03/31/10 End: 08/31/10 Due: 08/31/11

CKD-581 + Bortezomib + Dexamethasone in Patients With Previously Treated Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03051841 Org: User:
Start: 01/31/17 End: 11/30/22 Due: 11/30/23

The Study to Evaluate Efficacy and Safety of Celecoxib Capsule in Hand Osteoarthritis Patients

Phase: N/A Priority: Normal
NCT ID: NCT03067194 Org: User:
Start: 12/27/16 End: 11/20/18 Due: 11/20/19

Study to Evaluate the Efficacy and Safety of CKD-352

Phase: N/A Priority: Normal
NCT ID: NCT04548427 Org: User:
Start: 09/22/20 End: 05/07/21 Due: 05/07/22

Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 Under Fed Condition

Phase: N/A Priority: Normal
NCT ID: NCT03849339 Org: User:
Start: 01/28/19 End: 02/28/19 Due: 02/28/20